A similar analysis in BRCA1 vs BRCA2 tumours highlighted increase in PPI co-expression around the mitotic regulators CDK1, CDC20 and CKS1B and the histone deacetylases HDAC1 and HDAC6; these are known drug targets for which inhibitors have been developed [61,62]. The gene discussed is HDAC6; the disease is neoplasm.